Antipsychotic Polypharmacy vs. Monotherapy in Schizophrenia
In a nationwide cohort of 61,889 people with schizophrenia in Finland, the risk of hospitalization for severe physical health problems was no lower with monotherapy
In a nationwide cohort of 61,889 people with schizophrenia in Finland, the risk of hospitalization for severe physical health problems was no lower with monotherapy
Between 2017 and 2021, the number of clinicians with 30-patient buprenorphine waivers under the Drug Addiction Treatment Act (DATA) increased in the U.S. Still, nearly
In a study of melatonin gummy products purchased in the U.S., “the great majority … were inaccurately labeled, with most products exceeding the declared amount
Only 1 in 5 patients initiating monthly buprenorphine therapy in Jan. 2016 through Oct. 2022 continued treatment for opioid use disorder for at least 180
Among people with dementia (PWD), new use of psychotropic medications is rare during hospitalizations, a retrospective study reports, but “prolonged use of newly initiated psychotropics
In a guideline from the American Society of Clinical Oncology, a multimodal, stepped-care approach is recommended for managing anxiety and depression in adult cancer survivors.
In 2017, the use of benzodiazepines and antipsychotic agents differed markedly among 1.4 million hospice-enrolled Medicare beneficiaries aged 65 years or older across factors other than
Among Ontario nursing home residents, concomitant use of benzodiazepines (BZDs) or gabapentinoids with opioids continues, but different patterns of co-use are appearing, a study shows.
In the Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM) trial, outcomes were better when current antidepressants were augmented with aripiprazole rather than discontinued
In the Comprehensive Post-Acute Stroke Services (COMPASS) Study, statin prescribing remains lower among White patients, in those with transient ischemic attack (TIA), and in those